Management of pituicytomas: a multicenter series of eight cases

Pituitary. 2018 Oct;21(5):507-514. doi: 10.1007/s11102-018-0905-3.

Abstract

Purpose: Pituicytomas and spindle cell oncocytomas (SCOs) are two rare neoplasms of the sellar and suprasellar region, known to be challenging as they are extremely vascular and almost always misdiagnosed, altering our surgical planning and the patients' outcomes. Also we argue that recent update concerning the pathology findings of these tumors should be more widely generalized to our practice.

Methods: This is a retrospective multicenter study, reporting the clinical manifestations, radiological characteristics, histopathological features, treatment strategies and long-term outcomes of patients who have been treated for a Pituicytoma at various institutions in Paris, France over the past 10 years. In addition, we compared our results to the world literature in order to identify similarities concerning the radiographic diagnosis and the treatment strategies of these tumors.

Results: Eight patients were operated on in four different hospitals. Misdiagnosis was constant before surgery, pituitary adenoma or craniopharyngioma being suspected. During surgery (transsphenoidal approach: six cases, transcranial approach: two cases) unusual tumors were noted, with important bleeding in most cases. Complete resection could be obtained in five patients. Pathological diagnosis was confirmed in all cases. During the follow up two recurrences occurred. One was subsequently treated with radiotherapy, the other underwent a second surgery.

Conclusion: Recent updates concerning the histological diagnosis of pituicytomas should be generalized to our practice in order to provide a better understanding of this rare pathology and its natural course.

Keywords: Flow voids; Non-neuroendocrine tumor of the sella; Pituicytoma; Rare tumor of the sella; Spindle cell oncocytoma.

Publication types

  • Multicenter Study

MeSH terms

  • Adenoma / surgery
  • Adult
  • Craniopharyngioma / surgery
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pituitary Neoplasms / surgery*
  • Retrospective Studies